HK1077830A1 - Crystals of glucopyranosyloxybenzyl benzene derivative - Google Patents
Crystals of glucopyranosyloxybenzyl benzene derivativeInfo
- Publication number
- HK1077830A1 HK1077830A1 HK05109901A HK05109901A HK1077830A1 HK 1077830 A1 HK1077830 A1 HK 1077830A1 HK 05109901 A HK05109901 A HK 05109901A HK 05109901 A HK05109901 A HK 05109901A HK 1077830 A1 HK1077830 A1 HK 1077830A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- crystals
- benzene derivative
- glucopyranosyloxybenzyl
- glucopyranosyloxybenzyl benzene
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002081038 | 2002-03-22 | ||
PCT/JP2003/002466 WO2003080635A1 (fr) | 2002-03-22 | 2003-03-04 | Cristaux de derive de glucopyranosyloxybenzylbenzene |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1077830A1 true HK1077830A1 (en) | 2006-02-24 |
Family
ID=28449107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05109901A HK1077830A1 (en) | 2002-03-22 | 2005-11-07 | Crystals of glucopyranosyloxybenzyl benzene derivative |
Country Status (14)
Country | Link |
---|---|
US (1) | US7371730B2 (es) |
EP (1) | EP1489089A4 (es) |
JP (1) | JP4490109B2 (es) |
KR (1) | KR100945455B1 (es) |
CN (1) | CN1307190C (es) |
AU (1) | AU2003211543B2 (es) |
BR (1) | BR0308653A (es) |
CA (1) | CA2476800C (es) |
HK (1) | HK1077830A1 (es) |
MX (1) | MXPA04009229A (es) |
NO (1) | NO330297B1 (es) |
NZ (1) | NZ535230A (es) |
PL (1) | PL210710B1 (es) |
WO (1) | WO2003080635A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4490109B2 (ja) | 2002-03-22 | 2010-06-23 | キッセイ薬品工業株式会社 | グルコピラノシルオキシベンジルベンゼン誘導体の結晶 |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
CA2725047A1 (en) | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same |
WO2010009243A1 (en) | 2008-07-15 | 2010-01-21 | Theracos, Inc. | Deuterated benzylbenzene derivatives and methods of use |
TWI441831B (zh) | 2008-08-22 | 2014-06-21 | Theracos Inc | 製備sglt2抑制劑之方法 |
AU2009286380B2 (en) * | 2008-08-28 | 2011-09-15 | Pfizer Inc. | Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
SG173619A1 (en) | 2009-02-13 | 2011-09-29 | Boehringer Ingelheim Int | Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof |
US8420819B2 (en) * | 2009-06-03 | 2013-04-16 | Boehringer Ingelheim International Gmbh | Process for optimizing the particle size of an active pharmaceutical ingredient by crystallization |
ES2527179T3 (es) | 2009-11-02 | 2015-01-21 | Pfizer Inc. | Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol |
EP2552442A1 (en) | 2010-03-30 | 2013-02-06 | Boehringer Ingelheim International GmbH | Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof |
WO2011153712A1 (en) | 2010-06-12 | 2011-12-15 | Theracos, Inc. | Crystalline form of benzylbenzene sglt2 inhibitor |
WO2012025857A1 (en) | 2010-08-23 | 2012-03-01 | Hetero Research Foundation | Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors |
US20120283169A1 (en) | 2010-11-08 | 2012-11-08 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
US20130035281A1 (en) | 2011-02-09 | 2013-02-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
EP2714052B1 (en) | 2011-06-03 | 2018-09-19 | Boehringer Ingelheim International GmbH | Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents |
US9193751B2 (en) | 2012-04-10 | 2015-11-24 | Theracos, Inc. | Process for the preparation of benzylbenzene SGLT2 inhibitors |
EP4245765A3 (en) | 2013-04-04 | 2024-03-20 | Boehringer Ingelheim Vetmedica GmbH | Treatment of metabolic disorders in equine animals |
CN105611920B (zh) | 2013-10-12 | 2021-07-16 | 泰拉科斯萨普有限责任公司 | 羟基-二苯甲烷衍生物的制备 |
DK3082829T3 (da) | 2013-12-17 | 2021-05-03 | Boehringer Ingelheim Vetmedica Gmbh | Sglt2-inhibitorer til behandlingen af metaboliske lidelser i kattedyr |
LT3485890T (lt) | 2014-01-23 | 2023-07-25 | Boehringer Ingelheim Vetmedica Gmbh | Sglt2 inhibitoriai, skirti šuninių gyvūnų medžiagų apykaitos sutrikimų gydymui |
MX2016012705A (es) | 2014-04-01 | 2016-12-16 | Boehringer Ingelheim Vetmedica Gmbh | Tratamiento de trastornos metabolicos en animales equinos. |
US20210212968A1 (en) | 2016-10-19 | 2021-07-15 | Boehringer Ingelheim International Gmbh | Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof |
AU2019254371A1 (en) | 2018-04-17 | 2020-10-08 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
EA202190226A1 (ru) | 2018-07-19 | 2021-06-16 | Астразенека Аб | СПОСОБЫ ЛЕЧЕНИЯ HFpEF С ИСПОЛЬЗОВАНИЕМ ДАПАГЛИФЛОЗИНА И СОДЕРЖАЩИХ ЕГО КОМПОЗИЦИЙ |
MX2022006490A (es) | 2019-11-28 | 2022-07-04 | Boehringer Ingelheim Vetmedica Gmbh | Uso de inhibidores de sglt-2 en el secado de mamiferos no humanos. |
EP4106744A1 (en) | 2020-02-17 | 2022-12-28 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines |
TW202220672A (zh) | 2020-07-27 | 2022-06-01 | 瑞典商阿斯特捷利康公司 | 用達格列淨治療慢性腎臟病之方法 |
EP4315350A1 (en) | 2021-04-01 | 2024-02-07 | AstraZeneca UK Limited | Systems and methods for managing prediabetes with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition |
WO2023006745A1 (en) | 2021-07-28 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Use of sglt-2 inhibitors for the prevention and/or treatment of hypertension in non-human mammals |
CN117715640A (zh) | 2021-07-28 | 2024-03-15 | 勃林格殷格翰动物保健有限公司 | Sglt-2抑制剂用于在不包括猫科动物的非人哺乳动物,特别是犬科动物中预防和/或治疗心脏疾病的用途 |
CA3224673A1 (en) | 2021-07-28 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Use of sglt-2 inhibitors for the prevention and/or treatment of renal diseases in non-human mammals |
WO2023129595A1 (en) | 2021-12-30 | 2023-07-06 | Newamsterdam Pharma B.V. | Obicetrapib and sglt2 inhibitor combination |
WO2023144722A1 (en) | 2022-01-26 | 2023-08-03 | Astrazeneca Ab | Dapagliflozin for use in the treatment of prediabetes or reducing the risk of developing type 2 diabetes |
WO2023227492A1 (en) | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1270584B1 (en) | 2000-03-17 | 2005-12-07 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
US6683056B2 (en) * | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
WO2002028872A1 (fr) * | 2000-09-29 | 2002-04-11 | Kissei Pharmaceutical Co., Ltd. | Derives de glucopyranosiloxybenzylbenzene et compositions therapeutiques contenant ces composes |
JP4490109B2 (ja) | 2002-03-22 | 2010-06-23 | キッセイ薬品工業株式会社 | グルコピラノシルオキシベンジルベンゼン誘導体の結晶 |
-
2003
- 2003-03-04 JP JP2003578388A patent/JP4490109B2/ja not_active Expired - Fee Related
- 2003-03-04 US US10/507,611 patent/US7371730B2/en not_active Expired - Fee Related
- 2003-03-04 WO PCT/JP2003/002466 patent/WO2003080635A1/ja active Application Filing
- 2003-03-04 EP EP03744982A patent/EP1489089A4/en not_active Withdrawn
- 2003-03-04 AU AU2003211543A patent/AU2003211543B2/en not_active Ceased
- 2003-03-04 CN CNB038064847A patent/CN1307190C/zh not_active Expired - Fee Related
- 2003-03-04 KR KR1020047014801A patent/KR100945455B1/ko not_active IP Right Cessation
- 2003-03-04 BR BR0308653-4A patent/BR0308653A/pt not_active IP Right Cessation
- 2003-03-04 MX MXPA04009229A patent/MXPA04009229A/es active IP Right Grant
- 2003-03-04 PL PL372415A patent/PL210710B1/pl not_active IP Right Cessation
- 2003-03-04 NZ NZ535230A patent/NZ535230A/en not_active IP Right Cessation
- 2003-03-04 CA CA2476800A patent/CA2476800C/en not_active Expired - Fee Related
-
2004
- 2004-10-19 NO NO20044426A patent/NO330297B1/no not_active IP Right Cessation
-
2005
- 2005-11-07 HK HK05109901A patent/HK1077830A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20040099347A (ko) | 2004-11-26 |
PL210710B1 (pl) | 2012-02-29 |
AU2003211543B2 (en) | 2009-03-12 |
US7371730B2 (en) | 2008-05-13 |
NZ535230A (en) | 2006-10-27 |
BR0308653A (pt) | 2005-02-15 |
EP1489089A1 (en) | 2004-12-22 |
KR100945455B1 (ko) | 2010-03-05 |
JP4490109B2 (ja) | 2010-06-23 |
NO330297B1 (no) | 2011-03-21 |
CA2476800C (en) | 2010-08-17 |
JPWO2003080635A1 (ja) | 2005-07-21 |
MXPA04009229A (es) | 2004-11-26 |
CN1307190C (zh) | 2007-03-28 |
PL372415A1 (en) | 2005-07-25 |
US20050119192A1 (en) | 2005-06-02 |
NO20044426L (no) | 2004-12-22 |
WO2003080635A1 (fr) | 2003-10-02 |
EP1489089A4 (en) | 2009-10-28 |
AU2003211543A1 (en) | 2003-10-08 |
CN1642965A (zh) | 2005-07-20 |
CA2476800A1 (en) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1077830A1 (en) | Crystals of glucopyranosyloxybenzyl benzene derivative | |
IL166202A0 (en) | Azolidinone-vinyl benzene derivatives | |
GB0212412D0 (en) | Combination of organic compounds | |
PL372369A1 (en) | Combination of organic compounds | |
HK1082497A1 (en) | Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative | |
HUS1400037I1 (hu) | Új 2-piridiletilbenzamid származékok | |
AP2005003343A0 (en) | Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors | |
EP1537102A4 (en) | INHIBITORS OF PHOSPHOINOSITIDE-3-KINASE BETA | |
SI2932981T1 (sl) | Albumin-vezavni derivati GLP-1 | |
HK1084043A1 (en) | Derivatives of aryl-quinazoline/aryl-2amino-phenylmethanone which promote the release of parathyroidhormone | |
EP1485335A4 (en) | PRODUCTION OF ALKYL AROMATIC COMPOUNDS | |
EG23458A (en) | Set of elements for assemlying structures | |
ZA200500294B (en) | Novel 2-pyridylethylbenzamide derivative | |
AU2002330453A1 (en) | Crystals of hydroxynorephedrine derivative | |
AP1955A (en) | Novel crystalline modification of the anhydrate ofboscalid | |
AU2003202281A1 (en) | Mixtures of quaternary compounds | |
AU2003268687A1 (en) | Novel salt of 2-acylaminothiazole derivative | |
TWI367754B (en) | New carboxamide compound | |
EP1572950A3 (en) | Single domain tdf-related compounds and analogs thereof | |
EP1572950A4 (en) | SINGLE-DOMAIN-TDF-RELATED CONNECTIONS AND ANALOGS OF IT | |
AU2003246963A8 (en) | Synthesis of cyclohexanone derivatives | |
AU2003282510A8 (en) | Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents | |
GB0207623D0 (en) | Crystal structure of g-quadruplex | |
EP1486485A4 (en) | NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS | |
AU2003262141A8 (en) | Preperation of desloratatine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120304 |